Pages that link to "Q46899624"
Jump to navigation
Jump to search
The following pages link to Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study (Q46899624):
Displaying 50 items.
- Eating disorders in schizophrenia: implications for research and management (Q21284525) (← links)
- Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems (Q24235450) (← links)
- Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis (Q26748476) (← links)
- The potential role of appetite in predicting weight changes during treatment with olanzapine (Q33692484) (← links)
- Circuits controlling energy balance and mood: inherently intertwined or just complicated intersections? (Q33717463) (← links)
- Safety, tolerability, and risks associated with first- and second-generation antipsychotics: a state-of-the-art clinical review (Q33878816) (← links)
- Weight gain and glucose dysregulation with second-generation antipsychotics and antidepressants: a review for primary care physicians (Q34033259) (← links)
- Reduced accumbens dopamine in Sprague-Dawley rats prone to overeating a fat-rich diet (Q34095392) (← links)
- Metformin for olanzapine‐induced weight gain: a systematic review and meta‐analysis (Q34161953) (← links)
- The impact of antipsychotic drugs on food intake and body weight and on leptin levels in blood and hypothalamic ob-r leptin receptor expression in wistar rats (Q34197980) (← links)
- Lipid-lowering effects of tetradecylthioacetic acid in antipsychotic-exposed, female rats: challenges with long-term treatment (Q34506022) (← links)
- Treatment response to the RENEW weight loss intervention in schizophrenia: impact of intervention setting (Q34619959) (← links)
- Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care (Q34623350) (← links)
- Antipsychotic drugs and obesity (Q34648940) (← links)
- Eating disorders and psychosis: Seven hypotheses (Q34761274) (← links)
- Management of atypical antipsychotic drug-induced weight gain: focus on metformin (Q34983478) (← links)
- Atypical antipsychotics and the neural regulation of food intake and peripheral metabolism (Q35115972) (← links)
- Metformin and berberine prevent olanzapine-induced weight gain in rats (Q35131343) (← links)
- Obesity and Serious Mental Ill Health: A Critical Review of the Literature (Q37069133) (← links)
- Treatment of obese patients with binge eating disorder using topiramate: a review (Q37271279) (← links)
- Behavioural adverse effects of dopaminergic treatments in Parkinson's disease: incidence, neurobiological basis, management and prevention. (Q37491183) (← links)
- Olanzapine dosing above the licensed range is more efficacious than lower doses: fact or fiction? (Q37546091) (← links)
- Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use. (Q37638007) (← links)
- The Current Status of the Ketogenic Diet in Psychiatry (Q37710385) (← links)
- Metabolic syndrome associated with schizophrenia and atypical antipsychotics (Q37738743) (← links)
- Eating disorders and schizophrenia in male patients: a review (Q37979999) (← links)
- A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine. (Q37998840) (← links)
- Amantadine for olanzapine-induced weight gain: a systematic review and meta-analysis of randomized placebo-controlled trials (Q38132164) (← links)
- Modelling olanzapine-induced weight gain in rats (Q38150595) (← links)
- The effects of second-generation antipsychotics on food intake, resting energy expenditure and physical activity (Q38170310) (← links)
- Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. (Q38741061) (← links)
- Atypical antipsychotics and effects on feeding: from mice to men. (Q38850666) (← links)
- Managing comorbid obesity and depression through clinical pharmacotherapies (Q38859885) (← links)
- Disordered eating attitudes in Egyptian antipsychotic naive patients with schizophrenia (Q39000941) (← links)
- Substantial weight gain associated with severe carbohydrate craving in a patient receiving quetiapine (Q44010016) (← links)
- Early perturbation in feeding behaviour and energy homeostasy in olanzapine-treated rats. (Q45942751) (← links)
- Aripiprazole in anorexia nervosa and low-weight bulimia nervosa: case reports (Q46208591) (← links)
- Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine. (Q46217077) (← links)
- Smoking and weight among patients using clozapine (Q47173896) (← links)
- The atypical antipsychotic olanzapine causes weight gain by targeting serotonin receptor 2C. (Q47194413) (← links)
- Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain (Q47239890) (← links)
- Subjective and biological weight-related parameters in adolescents and young adults with schizophrenia spectrum disorder under clozapine or olanzapine treatment (Q47313793) (← links)
- Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters (Q47332928) (← links)
- The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature (Q47377449) (← links)
- Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity (Q48336234) (← links)
- Usefulness of the Mini Nutritional Assessment (MNA) in predicting the nutritional status of people with mental disorders in Taiwan (Q48931861) (← links)
- Binge eating and other eating behaviors among patients on treatment for psychoses in India (Q48948377) (← links)
- Cardiovascular effects of acute treatment with the antipsychotic drug olanzapine in rats. (Q50635982) (← links)
- Olanzapine and food craving: a case control study (Q50735172) (← links)
- Dietary intake of adults with serious mental illness (Q50782387) (← links)